ntrk

Roche Pharma Acquires Ignyta for $1.7 billion

Roche Pharma Acquires Ignyta for $1.7 billion

2120 | 0

Roche Holdings entered into a definitive agreement  with Ignyta Inc. (NASDAQ: RXDX) to acquire the biotech company specialized in the oncology field. Under the agreement, Roche agreed to purchase Ignyta at a price of $27.00 per share in cash. I..


@Newsletter

Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Trending Financialinsiders News

No articles found.

All rights reserved.

No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).